symkevi
vertex pharmaceuticals (ireland) limited - tezacaftor, ivacaftor - kystinen fibroosi - muut hengitysteiden tuotteet - symkevi is indicated in a combination regimen with ivacaftor tablets for the treatment of patients with cystic fibrosis (cf) aged 6 years and older who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t.
nivolumab bms
bristol-myers squibb pharma eeig - nivolumab - karsinooma, ei-pienisoluinen keuhko - syöpälääkkeet ja immuunivasteen aineet, monoklonaaliset vasta-aineet - nivolumab bms on tarkoitettu hoidettaessa paikallisesti kehittynyttä tai metastaattista squamous-ei-pienisoluista keuhkosyöpä (nsclc) aikuisen aiemman kemoterapian jälkeen.
zerit
bristol-myers squibb pharma eeig - stavudiini - hiv-infektiot - antiviraalit systeemiseen käyttöön - kova capsuleszerit on tarkoitettu yhdessä muiden antiretroviraalisten lääkevalmisteiden kanssa hiv-tartunnan aikuisille potilaille ja lapsipotilaille (yli kolme kuukautta) vain silloin, kun muiden antiretroviraalisten lääkkeiden ei voida käyttää. hoidon keston zerit olisi rajoitettava mahdollisimman nopeasti. jauhe suun solutionzerit on tarkoitettu yhdessä muiden antiretroviraalisten lääkevalmisteiden kanssa hiv-tartunnan aikuisille potilaille ja lapsipotilaille (syntymästä) vain silloin, kun muiden antiretroviraalisten lääkkeiden ei voida käyttää. hoidon keston zerit olisi rajoitettava mahdollisimman nopeasti.
rennie peppermint imeskelytabletti
bayer oy - calcium carbonate, magnesium carbonate, heavy - imeskelytabletti - tavanomaiset aluminium/kalsium/magnesiumyhdisteet
rennie spearmint imeskelytabletti
bayer oy - calcium carbonate, magnesium carbonate, heavy - imeskelytabletti - tavanomaiset aluminium/kalsium/magnesiumyhdisteet
rennie lakritsi imeskelytabletti
bayer oy - calcium carbonate, magnesium carbonate, heavy - imeskelytabletti - tavanomaiset aluminium/kalsium/magnesiumyhdisteet
rennie orange imeskelytabletti
bayer oy - calcium carbonate, magnesium carbonate, heavy - imeskelytabletti - tavanomaiset aluminium/kalsium/magnesiumyhdisteet
kalydeco
vertex pharmaceuticals (ireland) limited - ivacaftor - kystinen fibroosi - muut hengitysteiden tuotteet - kalydeco tablets are indicated:as monotherapy for the treatment of adults, adolescents, and children aged 6 years and older and weighing 25 kg or more with cystic fibrosis (cf) who have an r117h cftr mutation or one of the following gating (class iii) mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: g551d, g1244e, g1349d, g178r, g551s, s1251n, s1255p, s549n or s549r (see sections 4. 4 ja 5. in a combination regimen with tezacaftor/ivacaftor tablets for the treatment of adults, adolescents, and children aged 6 years and older with cystic fibrosis (cf) who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cftr gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t. in a combination regimen with ivacaftor/tezacaftor/elexacaftor tablets for the treatment of adults, adolescents, and children aged 6 years and older with cystic fibrosis (cf) who have at least one f508del mutation in the cftr gene (see section 5. kalydeco granules are indicated for the treatment of infants aged at least 4 months, toddlers and children weighing 5 kg to less than 25 kg with cystic fibrosis (cf) who have an r117h cftr mutation or one of the following gating (class iii) mutations in the cftr gene: g551d, g1244e, g1349d, g178r, g551s, s1251n, s1255p, s549n or s549r (see sections 4. 4 ja 5. in a combination regimen with ivacaftor/tezacaftor/elexacaftor for the treatment of cystic fibrosis (cf) in paediatric patients aged 2 to less than 6 years who have at least one f508del mutation in the cftr gene.
berocca orange poretabletti
bayer oy - nicotinamidum,thiamini hydrochloridum anhydricum,biotinum,magnesii subcarbonas ponderosus,calcii carbonas,riboflavini natrii phosphas,acidum folicum,magnesii sulfas dihydricus,thiamini monophosphas chloridum dihydricum,acidum ascorbicum,pyridoxini hydrochloridum,riboflavinum,cyanocobalaminum,calcii pantothenas,zinci citras trihydricus - poretabletti - b-vitamiinien muut yhdistelmävalmisteet
nutriflex lipid 32/64/40 perifer infuusioneste, emulsio
b. braun melsungen ag - aspartic acid, glutamic acid, alanine, arginine, calcium chloride dihydrate, glucose monohydrate, aminoacetic acid, isoleucine, potassium acetate, histidine hydrochloride monohydrate, leucine, methionine, phenylalanine, proline, serine, threonine, tryptophane, valine, lysine hydrochloride, sodium acetate trihydrate, sodium chloride, sodium dihydrogen phosphate dihydrate, sodium hydroxide, zinc acetate dihydrate, triglycerides, medium-chain, magnesium acetate tetrahydrate, soya-bean oil, refined - infuusioneste, emulsio - yhdistelmävalmisteet